ENDRA Life Sciences IncNASDAQ:NDRA
- LAST PRICE1.3900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.4000/ 6
- Ask / Lots1.4600/ 1
- Open / Previous Close0.0000 / 1.3900
- Day Range---
- 52 Week Range
- Volume149
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NDRA |
|---|---|---|
| 09:32 ET | 4545 | 1.36 |
| 09:33 ET | 1800 | 1.43 |
| 09:35 ET | 100 | 1.43 |
| 09:37 ET | 6500 | 1.45 |
| 09:39 ET | 100 | 1.439 |
| 09:50 ET | 3482 | 1.4911 |
| 09:51 ET | 500 | 1.45 |
| 09:53 ET | 1350 | 1.4901 |
| 09:55 ET | 1554 | 1.51 |
| 09:57 ET | 500 | 1.5 |
| 10:00 ET | 3150 | 1.5 |
| 10:04 ET | 500 | 1.48 |
| 10:06 ET | 400 | 1.49 |
| 10:08 ET | 6050 | 1.529 |
| 10:13 ET | 700 | 1.505 |
| 10:15 ET | 2543 | 1.55 |
| 10:18 ET | 1400 | 1.55 |
| 10:20 ET | 11654 | 1.59 |
| 10:22 ET | 12146 | 1.55 |
| 10:24 ET | 11800 | 1.5 |
| 10:26 ET | 7021 | 1.4501 |
| 10:31 ET | 8924 | 1.4 |
| 10:36 ET | 1228 | 1.39 |
| 10:38 ET | 2299 | 1.3715 |
| 10:40 ET | 4424 | 1.5686 |
| 10:42 ET | 4000 | 1.4491 |
| 10:44 ET | 2000 | 1.4305 |
| 10:45 ET | 4061 | 1.43 |
| 10:51 ET | 4959 | 1.5 |
| 10:54 ET | 7200 | 1.4405 |
| 11:00 ET | 3000 | 1.5699 |
| 11:02 ET | 1000 | 1.46 |
| 11:03 ET | 500 | 1.41 |
| 11:05 ET | 2000 | 1.38 |
| 11:23 ET | 2600 | 1.38 |
| 11:25 ET | 1500 | 1.38 |
| 11:27 ET | 1000 | 1.405 |
| 11:30 ET | 2100 | 1.38 |
| 11:32 ET | 200 | 1.4 |
| 11:34 ET | 849 | 1.41 |
| 11:36 ET | 3457 | 1.36 |
| 11:38 ET | 2832 | 1.36 |
| 11:45 ET | 1268 | 1.36 |
| 11:50 ET | 100 | 1.37 |
| 11:54 ET | 6341 | 1.3986 |
| 12:03 ET | 100 | 1.39 |
| 12:06 ET | 709 | 1.38 |
| 12:10 ET | 300 | 1.375 |
| 12:21 ET | 10252 | 1.385 |
| 12:24 ET | 2600 | 1.4 |
| 12:26 ET | 1200 | 1.39 |
| 12:28 ET | 500 | 1.39 |
| 12:30 ET | 4100 | 1.4 |
| 12:32 ET | 800 | 1.38 |
| 12:33 ET | 16263 | 1.345 |
| 12:39 ET | 250 | 1.337 |
| 12:44 ET | 100 | 1.3 |
| 12:53 ET | 106 | 1.2801 |
| 01:40 ET | 3768 | 1.32 |
| 01:42 ET | 1589 | 1.3 |
| 01:54 ET | 250 | 1.32 |
| 02:16 ET | 3959 | 1.33 |
| 02:36 ET | 999 | 1.34 |
| 02:43 ET | 1100 | 1.33 |
| 02:56 ET | 22100 | 1.35 |
| 03:08 ET | 200 | 1.3564 |
| 03:14 ET | 9939 | 1.4683 |
| 03:26 ET | 100 | 1.405 |
| 03:50 ET | 1852 | 1.38 |
| 03:51 ET | 1325 | 1.376 |
| 03:57 ET | 100 | 1.34 |
| 04:00 ET | 388 | 1.39 |
Nov 29, 2023
ENDRA Life Sciences Secures 39(th) U.S. Patent for TAEUS(R) System Technology, from 8:00AM ET on Wednesday Nov 29, 2023 by Dow Jones
8:00AM ET on Wednesday Nov 29, 2023 by Dow Jones
Nov 27, 2023
ENDRA Life Sciences to Participate in The Benchmark Company's 12(th) Annual Discovery One-on-One Investor Conference, from 8:00AM ET on Monday Nov 27, 2023 by Dow Jones
8:00AM ET on Monday Nov 27, 2023 by Dow Jones
Nov 14, 2023
Press Release: ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update, from 4:08PM ET on Tuesday Nov 14, 2023 by Dow Jones
4:08PM ET on Tuesday Nov 14, 2023 by Dow JonesENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update, from 4:05PM ET on Tuesday Nov 14, 2023 by Dow Jones
4:05PM ET on Tuesday Nov 14, 2023 by Dow Jones
Nov 8, 2023
ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents, from 8:00AM ET on Wednesday Nov 08, 2023 by Dow Jones
8:00AM ET on Wednesday Nov 08, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ENDRA Life Sciences Inc | 11.8M | -0.5x | --- |
Aslan Pharmaceuticals Ltd | 11.7M | -0.2x | --- |
Dominari Holdings Inc | 11.8M | -0.5x | --- |
Inhibitor Therapeutics Inc | 11.4M | 2.6x | --- |
Forward Pharma A/S | 11.2M | 0.0x | --- |
Edesa Biotech Inc | 12.4M | -1.1x | --- |
Company Information
ENDRA Life Sciences Inc. develops technology for increasing the capabilities of clinical diagnostic ultrasound to broaden patient access to the diagnosis and treatment of various medical conditions in circumstances where other diagnostic technologies are unavailable or impractical. The Company has developed a technology platform, Thermo Acoustic Enhanced Ultrasound (TAEUS), which is intended to enhance the capability of clinical ultrasound technology and support the diagnosis and treatment of various other medical conditions. Its TAEUS technology platform application focuses on quantifying fat in the liver and staging the progression of non-alcoholic fatty liver disease (NAFLD), which, if untreated, can progress to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and liver cancer. The Company's TAEUS platform has various clinical applications, such as tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.
Contact Information
- Headquarters
- 3600 Green Ct Ste 350ANN ARBOR, MI, United States 48105-2440
- Phone
- 734-335-0468
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer
- Francois Michelon
- Senior Director of Finance
- Irina Pestrikova
- Chief Technology Officer
- Michael Thornton
- Independent Director
- Louis Basenese
- Independent Director
- Anthony DiGiandomenico
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 8.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.90 |
EPS | $-2.80 |
Book Value | $2.27 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
